BPG is committed to discovery and dissemination of knowledge
Citation
Wang YC, Zhang CG, Wang YW, Guo C, Pan T, Yu PJ, Cai BJ, Ding RH, Qiang JL, Deng CQ, Hu CH, Xu YH. SOX plus sintilimab vs P-SOX vs SOX as neoadjuvant therapy in advanced gastric cancer: Efficacy and safety. World J Gastrointest Oncol 2025; 17(8): 109646 [PMID: 40837776 DOI: 10.4251/wjgo.v17.i8.109646]
Please LOGIN to submit a new comment.
Write to the Help Desk